Markets, explained.

Hormuz Deadlock and China's Retaliation Squeeze Markets From Both Ends

Record-High S&P 500 Faces Its CPI Hinge After AI-Earnings Euphoria

Biotech IPOs Lead August as SpaceX Unlock and Reg NMS Overhaul Reshape Market Structure

August 2026 IPO market analysis: biotech-dominated issuance, SpaceX $101B lock-up unlock, SEC Reg NMS trade-through rule rescission proposal, and FINRA best-execution review.

Three Fronts at Once: Why Hormuz, China, and Russian Sanctions Are Converging Into a Single Supply Shock

The market is pricing three geopolitical risks as one: a Hormuz waterway still 75% shut, a US-China trade war entering its sanctions-mirror phase, and a Senate bill that would impose 100% tariffs on buyers of Russian oil. Brent crude settled at $83.55 on Friday, yet energy equities sold off — a divergence that signals demand-destruction fears, not just supply loss.

Record Highs on Shifting Sand: The S&P 500's Strongest Week Since April Papers Over a Jobs Market Gone Quiet

The S&P 500 posted its strongest week since April, up 3.6% to a record close, as Iran de-escalation and strong earnings cleared the market's biggest summer headwinds. But a surprise July payroll decline and a VIX at six-month lows leave the rally sitting on a fault line — with CPI on August 12 as the next test.

August's IPO Market Opens Hot: Biotech Wave, SpaceX Lockup, and Switch's $50B Filing

August's first week delivered the busiest biotech IPO stretch since April — four upsized deals raising $1.17B — while SpaceX's record lockup freed 911M shares and Switch confidentially filed for a data-center mega-IPO potentially approaching $50B.

Three Geopolitical Chokepoints Tighten at Once: Hormuz, Russian Energy, and US-China Trade

Strait of Hormuz vessel traffic is down 90% with LNG exports through the waterway collapsed 95%. The Senate passed 100% tariffs on Russian energy importers. China launched its broadest trade retaliation since the Busan truce. Brent crude held near $83 even after a 7% weekly drop, while the S&P 500 closed at a record 7,757.

A Bad Jobs Report Was Exactly What the Market Wanted

A surprise loss of 23,000 July payrolls took a September rate hike off the table, driving the S&P 500 to a record close and the Nasdaq up 1.3%. But with VIX at 15, consumer sentiment near cycle lows, and CPI data looming, the calm may be thinner than it looks.

SpaceX's $100 Billion Lockup Test: What the Market's Non-Event Reveals About IPO Supply

SpaceX's first post-IPO lockup expiry freed 911.5 million shares worth roughly $100 billion — and the stock rose 6%. The non-event tells us something important about the depth of the buyer base, the mechanics of block-crossing, and the market's capacity to absorb supply. But the staggered unlock schedule runs through mid-2027, and a resurgent IPO calendar is adding new issuance on top.

Three-Front Geopolitical Squeeze: Hormuz, Russian Sanctions, and China Retaliation Converge

Three geopolitical risk fronts converged in August 2026: Strait of Hormuz traffic at 4% of pre-war levels, the Senate's 86-11 Russian energy sanctions bill, and China's broadest trade retaliation since the Busan truce. All three test September's political calendar.

The S&P 500's Record High Came With a Paradox

The S&P 500 broke 7,700 for the first time, fueled by a weak July jobs report and record call-option volume. But long-end yields at 19-year highs and earnings beats inflated by non-operating gains complicate the soft-landing narrative.

Equity Supply Stress Test: Can This Market Digest Billions in a Week?

A single week in August 2026 delivered one of the most concentrated bursts of equity supply in years. The market absorbed it without flinching, but the back half of the year has much more in store.